|
|
Volumn 11, Issue 2, 2002, Pages 153-157
|
|
Re-emergence of tuberculosis: Strategies and treatment
a
a
|
|
Author keywords
Antitubercular drugs; BCG; Mycobacterium tuberculosis; Vaccines
|
|
Indexed keywords
3 OXOACYL ACYL CARRIER PROTEIN SYNTHASE;
ALPHA CRYSTALLIN;
AMINOSALICYLIC ACID DERIVATIVE;
ANTIMYCOBACTERIAL AGENT;
ARABINOGALACTAN;
BCG VACCINE;
CD8 ANTIGEN;
CLOFAZIMINE;
CYCLOSERINE;
DNA VACCINE;
ETHAMBUTOL;
ETHIONAMIDE;
GALACTOSYLTRANSFERASE;
ISOCITRATE LYASE;
ISONIAZID;
KANAMYCIN;
LISTERIOLYSIN;
MACROLIDE;
METRONIDAZOLE;
MYCOBACTERIUM VACCINE;
MYCOLIC ACID;
PYRAZINAMIDE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
STREPTOMYCIN;
SUBUNIT VACCINE;
THIOACETAZONE;
TIOCARLIDE;
TUBERCULOSTATIC AGENT;
AUXOTROPHY;
BACTERIAL STRAIN;
BCG VACCINATION;
CONTROLLED STUDY;
COST OF ILLNESS;
DEVELOPING COUNTRY;
DRUG COST;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG RESEARCH;
EDITORIAL;
HUMAN;
MORTALITY;
MULTIDRUG RESISTANCE;
MYCOBACTERIUM TUBERCULOSIS;
POPULATION RESEARCH;
TUBERCULOSIS;
WORLD HEALTH ORGANIZATION;
CLINICAL TRIAL;
DRUG EFFECT;
EPIDEMIC;
GENETICS;
IMMUNOLOGY;
LUNG TUBERCULOSIS;
RESEARCH;
ANTITUBERCULAR AGENTS;
BCG VACCINE;
CLINICAL TRIALS;
DISEASE OUTBREAKS;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
HUMANS;
MYCOBACTERIUM TUBERCULOSIS;
RESEARCH;
TUBERCULOSIS, PULMONARY;
VACCINES, DNA;
|
|
EID: 0036168684
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.11.2.153 Document Type: Editorial |
|
Times cited : (24)
|
|
References (19)
|
